BioGlue Used In Over Half a Million Surgeries

CryoLife, which specializes in implantable biological devices and surgical adhesives, announced that, according to company data, CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.  Comprised of purified bovine serum...

Aureon Featured In TV Segment

Aureon Laboratories, a developer of predictive tests for cancer care, has been featured in a cable television segment produced by the Yonkers Chamber of Commerce. This Week In Yonkers: Business Spotlight highlights Aureon’s efforts to develop a more accurate predictive test for prostate...

Clarient Files Registration Agreement With SEC

Safeguard Scientifics, a Pennsylvania-based investor in information technology and life sciences companies, announced that its portfolio company Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard. Safeguard...

SyntheMed Nominated for Frost & Sullivan Award

SyntheMed, a biomaterials company engaged in the development and commercialization of anti-adhesion products, has been nominated for the prestigious Frost & Sullivan Health Innovation Award in pediatrics. The Iselin, NJ-based company was recognized for its REPEL-CV Anti-Adhesion Barrier, a thin film...

CNS Closes $1M Bridge Loan, Completes Clinical Trial Enrollment

CNS Response announced that it has closed a $1 million bridge loan with venture capitalist John Pappajohn. Pappajohn has been involved in over 100 startups, including Caremark and Quantum Health. Over the past two months, CNS Response has closed two bridge loans totaling $1.2 million. The money will allow...

FDA Approves Kowa’s Cambia for Migraines

Kowa Pharmaceuticals America announced that the U.S. Food and Drug Administration has approved Cambia for the treatment of acute migraine headaches in adults. Cambia is a diclofenac-based non-steroidal anti-inflammatory drug (NSAID) combined with potassium bicarbonate. In clinical trials, Cambia not only...

BioNeutral Ships Mold-Fighting Ogiene-M Formulation

BioNeutral, a life science company that specializes in biohazard neutralization technologies, has started shipping its Ogiene-M formulation to fulfill an agreement between BioNeutral and Mr. Mold, a New Jersey-based mold remediation company that operates throughout the Northeast. The Ogiene-M formulation...

Promising Genetic Biomarker Identified for Colorectal Cancer

A new genetic discovery could lead to easier detection of colorectal cancer, Forbes reports. Researchers in the Netherlands, Belgium, and the U.S. have identified a genetic biomarker that correctly detects the presence of colorectal cancer more than half the time. The study, published online...